Clinical Trial Update: Primary Rituximab and Maintenance [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating primary rituximab therapy with maintenance for follicular lymphoma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Follicular Lymphoma

Drugs mentioned

• Rituxan (rituximab)

Snippet

Sponsor: Lymphoma Study Association | Conditions: Follicular Lymphoma | Phase 3 | Status: COMPLETED